Regulatory science session announced for Nexus Bergamo 2014iclaron
A regulatory science session is set to take place at the upcoming ISN Nexus Symposium in Bergamo, Italy.
“We are especially pleased to announce that all three major regulatory agencies – the FDA, the EMA and the PMDA – will be represented at the symposium, with speakers from all three giving what promises to be fascinating talks,” say symposium co-chairs Giuseppe Remuzzi and Toshio Miyata.
They will chair the regulatory science session, organized on Friday April 4, 2014. Aliza Thompson will cover regulatory issues and strategies by FDA. Tsuyoshi Ando will talk about current regulatory issues and strategies by PMDA and Romaldas Maciulaitis will speak about regulatory issues and strategies by EMA.
Taking place from April 3 to 6, 2014, this symposium brings together scientists in academia and the pharmaceutical sector, clinicians and regulators, to define new frameworks towards efficient drug discovery and clinical trials in kidney disease. The program is almost final and you will find the most up-to-date information on sessions and speakers at www.isnnexus.org/bergamo/program.